当前位置:首页 - 行情中心 - 国药现代(600420) - 财务分析 - 现金流量表

国药现代

(600420)

  

流通市值:116.15亿  总市值:116.15亿
流通股本:13.41亿   总股本:13.41亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,521,231,307.351,433,187,760.119,367,460,124.446,556,114,497.37
  收到的税费返还42,651,514.087,719,458.6842,838,500.1842,833,163.39
  收到其他与经营活动有关的现金79,717,479.0223,289,452.96189,428,213.28122,304,154.75
  经营活动现金流入小计3,643,600,300.451,464,196,671.759,599,726,837.96,721,251,815.51
  购买商品、接受劳务支付的现金2,221,280,473.311,085,520,820.394,130,391,864.22,858,346,117.6
  支付给职工以及为职工支付的现金744,961,468.33399,454,809.781,817,672,846.111,244,115,288.26
  支付的各项税费274,822,073.97153,833,077.22650,850,023.38509,896,460.46
  支付其他与经营活动有关的现金354,258,358.19188,701,903.931,302,723,050.88967,264,214.08
  经营活动现金流出小计3,595,322,373.81,827,510,611.327,901,637,784.575,579,622,080.4
  经营活动产生的现金流量净额48,277,926.65-363,313,939.571,698,089,053.331,141,629,735.11
二、投资活动产生的现金流量:
  收回投资收到的现金--3,030,562.96284,276.73
  取得投资收益收到的现金31,229,580.0523,570,739.8438,545,130.7224,526,859.41
  处置固定资产、无形资产和其他长期资产收回的现金净额992,1126006,153,234.93,268,112.46
  处置子公司及其他营业单位收到的现金净额--102,598,445.98-
  收到的其他与投资活动有关的现金3,478,610,416.671,965,610,416.674,484,682,991.483,381,348,250
  投资活动现金流入小计3,510,832,108.721,989,181,756.514,635,010,366.043,409,427,498.6
  购建固定资产、无形资产和其他长期资产支付的现金109,070,706.0456,656,829.03263,826,239.02206,804,927.07
  支付其他与投资活动有关的现金3,611,640,0001,883,640,0006,762,794,6254,877,422,125
  投资活动现金流出小计3,720,710,706.041,940,296,829.037,026,620,864.025,084,227,052.07
  投资活动产生的现金流量净额-209,878,597.3248,884,927.48-2,391,610,497.98-1,674,799,553.47
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金--40,000,000-
  筹资活动现金流入平衡项目--0-
  筹资活动现金流入小计--40,000,000-
  偿还债务支付的现金--1,050,000,0001,050,000,000
  分配股利、利润或偿付利息支付的现金278,341,538.4-512,929,759.63475,452,502.03
  其中:子公司支付给少数股东的股利、利润10,107,000-85,034,359.7744,755,390.22
  支付其他与筹资活动有关的现金6,372,423.325,273,823.32119,513,377.43115,519,644.07
  筹资活动现金流出小计284,713,961.725,273,823.321,682,443,137.061,640,972,146.1
  筹资活动产生的现金流量净额-284,713,961.72-5,273,823.32-1,642,443,137.06-1,640,972,146.1
四、汇率变动对现金及现金等价物的影响-13,914,140.26-6,150,170.8615,344,679.2418,636,588.38
五、现金及现金等价物净增加额-460,228,772.65-325,853,006.27-2,320,619,902.47-2,155,505,376.08
  加:期初现金及现金等价物余额3,824,394,182.043,824,394,182.046,145,014,084.516,145,014,084.51
  期末现金及现金等价物余额3,364,165,409.393,498,541,175.773,824,394,182.043,989,508,708.43
补充资料:
  净利润363,224,062.4-1,142,165,623.26-
  资产减值准备24,745,696.97-124,085,889.98-
  固定资产和投资性房地产折旧326,873,105.1-650,006,984.66-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧326,873,105.1-650,006,984.66-
  无形资产摊销33,306,625.78-66,898,259.37-
  长期待摊费用摊销2,856,157.47-6,622,737.91-
  处置固定资产、无形资产和其他长期资产的损失557,240.54-2,651,461.17-
  固定资产报废损失288,982.67-1,160,836.96-
  财务费用1,029,163.5-4,385,554-
  投资损失-48,798,945.94--133,898,891.94-
  递延所得税19,744,907.04--20,958,263.12-
  其中:递延所得税资产减少10,137,907--12,679,006.77-
    递延所得税负债增加9,607,000.04--8,279,256.35-
  存货的减少-149,545,353.72-485,711,359.68-
  经营性应收项目的减少-412,261,204.13-187,082,125.3-
  经营性应付项目的增加-127,345,257.02--833,490,187.71-
  现金的期末余额3,364,165,409.39-3,824,394,182.04-
  减:现金的期初余额3,824,394,182.04-6,145,014,084.51-
  现金及现金等价物的净增加额-460,228,772.65--2,320,619,902.47-
公告日期2026-08-272026-04-302026-03-282025-10-30
审计意见(境内)标准无保留意见
TOP↑